Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

ClinicalTrials.gov ID: NCT06775379

Public ClinicalTrials.gov record NCT06775379. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 11:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate Azetukalner in Moderate-to-Severe Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

X-NOVA2 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of azetukalner as a monotherapy in adult participants diagnosed with Major Depressive Disorder (MDD)

Study identification

NCT ID
NCT06775379
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Xenon Pharmaceuticals Inc.
Industry
Enrollment
450 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 74 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 20, 2024 (Actual)
Primary completion
Oct 2026 (Estimated)
Completion
Dec 2026 (Estimated)
Last update posted
Oct 13, 2026

2024 – 2026

United States locations

U.S. sites
45
U.S. states
18
U.S. cities
41
Facility City State ZIP Site status
IMA Clinical Research Phoenix Phoenix Arizona 85012 —
Woodland International Research Group Little Rock Arkansas 72211 —
Woodland Research Northwest Rogers Arkansas 72758 —
Irvine Clinical Research Irvine California 92614 —
CalNeuro Research Group, Inc. Los Angeles California 90025 —
Excell Research Inc. Oceanside California 92056 —
Atp Clinical Research Orange California 92866 —
Nrc Research Institute Orange California 92868 —
CenExel CNS-TO (Collaborative Neuroscience Research) Torrance California 90504 —
Sunwise Clinical Research Walnut Creek California 94596 —
Kinetic Clinical Research, LLC West Covina California 91790 —
Ct Clinical Research Associates Cromwell Connecticut 06416 —
CNS Clinical Research Group Coral Springs Florida 33067 —
NeoClinical Research Hialeah Florida 33016 —
Clinical Neuroscience Solutions, LLC Jacksonville Florida 32256 —
Accel Research Sites Lakeland Lakeland Florida 33803 —
Accel Research Sites - St. Petersburg-Largo Largo Florida 33777 —
PharmaSouth Research Miami Florida 33165 —
Quantum Clinical Trials Miami Beach Florida 33140 —
Harmony Clinical Research Inc North Miami Beach Florida 33162 —
Clinical Neuroscience Solutions, LLC Orlando Florida 32801 —
Combined Research Orlando Phase I-Iv Orlando Florida 32807 —
Panhandle Research and Medical Clinic Pensacola Florida 32503 —
Advanced Discovery Research Atlanta Georgia 30318 —
Synexus - Atlanta Atlanta Georgia 30328 —
CenExel iResearch Decatur Georgia 30030 —
Psych Atlanta, Pc Marietta Georgia 30060 —
Cenexel Iresearch - Savannah Savannah Georgia 31405 —
Northwest Clinical Trials Inc Boise Idaho 83704 —
IMA Clinical Research Chicago Illinois 60634 —
Boston Clinical Trials Llc Boston Massachusetts 02131 —
ELIXIA Springfield Massachusetts 01103 —
IMA Clinical Research Las Vegas Las Vegas Nevada 89102 —
Redbird Research Las Vegas Nevada 89119 —
Integrative Clinical Trials Brooklyn New York 11229 —
Richmond Behavioral Associates Staten Island New York 10314 —
New Hope Clinical Research Charlotte North Carolina 28211 —
Neuro-Behavioral Clinical Research North Canton Ohio 44720 —
Pahl Pharmaceutical Professionals Llc Oklahoma City Oklahoma 73112 —
Lehigh Center For Clinical Research Allentown Pennsylvania 18103 —
Adams Clinical - Philadelphia Philadelphia Pennsylvania 19104 —
Clinical Neuroscience Solutions, LLC Memphis Tennessee 38119 —
Delricht Research - Plano Plano Texas 75024 —
Grayline Research Center Wichita Falls Texas 76309 —
Core Clinical Research Everett Washington 98201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06775379, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 13, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06775379 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →